SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients
Abstract Background SET domain containing 5 (SETD5) is related to the aggressiveness of prostate and mammary cancers, but its association with non-small cell lung cancer (NSCLC) is unknown. Therefore, the purpose of this research was to determine the expression pattern and function of SETD5 in NSCLC...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5944-2 |
id |
doaj-32550c4e0f594b7e82bdbbf1a8adab63 |
---|---|
record_format |
Article |
spelling |
doaj-32550c4e0f594b7e82bdbbf1a8adab632020-11-25T02:48:04ZengBMCBMC Cancer1471-24072019-07-0119111010.1186/s12885-019-5944-2SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patientsHairu Yu0Jiayi Sun1Congxuan Zhao2Haotian Wang3Yeqiu Liu4Jiajia Xiong5Jing Chang6Mixue Wang7Wenhui Wang8Dongman Ye9Hongyan Zhou10Tao Yu11Department of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityThe First Clinical College, Dalian Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityDepartment of Medical Imaging, Cancer Hospital of China Medical UniversityAbstract Background SET domain containing 5 (SETD5) is related to the aggressiveness of prostate and mammary cancers, but its association with non-small cell lung cancer (NSCLC) is unknown. Therefore, the purpose of this research was to determine the expression pattern and function of SETD5 in NSCLC. Methods SETD5 was detected by immunohistochemical analysis in 147 patients with non-small cell lung cancer. SETD5 was overexpressed in A549 cells or suppressed with siRNA in H1299 cells. Wound healing and transwell assays were performed. The expression levels of SETD5, p-AKT/AKT, Snail, p-JNK/JNK, Slug, E-cadherin, Zo-1, p-P38/P38, occludin, α-catenin, p-ERK/ERK, and p-P90RSK/ P90RSK were assessed by western blot. Results Online analysis of overall survival in 1928 patients with NSCLC showed that the SETD5 gene was related to worse overall survival (OS)(P < 0.001). The positive expression rate of SETD5 in noncancerous tissues was lower than that in cancerous tissues (16.7% vs. 44.2%, P < 0.001). SETD5 was significantly correlated with advanced TNM stage (P < 0.001), lymph node metastasis (P < 0.001) and overall survival rate (P < 0.001). Overexpression of SETD5 in A549 cells increased migration and invasion, while deletion of SETD5 in H1299 cells decreased migration and invasion. After overexpression of SETD5, the expression of ZO-1 was downregulated, and that of Snail was upregulated. After overexpression of SETD5, the levels of p-ERK and its downstream factor p-p90rsk increased. Conclusion These results suggest that SETD5 could regulate p-P90RSK and facilitate the migration and invasion of NSCLC and may be related to the poor prognosis of patients with NSCLC.http://link.springer.com/article/10.1186/s12885-019-5944-2SET domain containing 5 (SETD5)Non-small cell lung cancerInvasionERK signalingPrognosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hairu Yu Jiayi Sun Congxuan Zhao Haotian Wang Yeqiu Liu Jiajia Xiong Jing Chang Mixue Wang Wenhui Wang Dongman Ye Hongyan Zhou Tao Yu |
spellingShingle |
Hairu Yu Jiayi Sun Congxuan Zhao Haotian Wang Yeqiu Liu Jiajia Xiong Jing Chang Mixue Wang Wenhui Wang Dongman Ye Hongyan Zhou Tao Yu SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients BMC Cancer SET domain containing 5 (SETD5) Non-small cell lung cancer Invasion ERK signaling Prognosis |
author_facet |
Hairu Yu Jiayi Sun Congxuan Zhao Haotian Wang Yeqiu Liu Jiajia Xiong Jing Chang Mixue Wang Wenhui Wang Dongman Ye Hongyan Zhou Tao Yu |
author_sort |
Hairu Yu |
title |
SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients |
title_short |
SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients |
title_full |
SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients |
title_fullStr |
SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients |
title_full_unstemmed |
SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients |
title_sort |
set domain containing protein 5 (setd5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2019-07-01 |
description |
Abstract Background SET domain containing 5 (SETD5) is related to the aggressiveness of prostate and mammary cancers, but its association with non-small cell lung cancer (NSCLC) is unknown. Therefore, the purpose of this research was to determine the expression pattern and function of SETD5 in NSCLC. Methods SETD5 was detected by immunohistochemical analysis in 147 patients with non-small cell lung cancer. SETD5 was overexpressed in A549 cells or suppressed with siRNA in H1299 cells. Wound healing and transwell assays were performed. The expression levels of SETD5, p-AKT/AKT, Snail, p-JNK/JNK, Slug, E-cadherin, Zo-1, p-P38/P38, occludin, α-catenin, p-ERK/ERK, and p-P90RSK/ P90RSK were assessed by western blot. Results Online analysis of overall survival in 1928 patients with NSCLC showed that the SETD5 gene was related to worse overall survival (OS)(P < 0.001). The positive expression rate of SETD5 in noncancerous tissues was lower than that in cancerous tissues (16.7% vs. 44.2%, P < 0.001). SETD5 was significantly correlated with advanced TNM stage (P < 0.001), lymph node metastasis (P < 0.001) and overall survival rate (P < 0.001). Overexpression of SETD5 in A549 cells increased migration and invasion, while deletion of SETD5 in H1299 cells decreased migration and invasion. After overexpression of SETD5, the expression of ZO-1 was downregulated, and that of Snail was upregulated. After overexpression of SETD5, the levels of p-ERK and its downstream factor p-p90rsk increased. Conclusion These results suggest that SETD5 could regulate p-P90RSK and facilitate the migration and invasion of NSCLC and may be related to the poor prognosis of patients with NSCLC. |
topic |
SET domain containing 5 (SETD5) Non-small cell lung cancer Invasion ERK signaling Prognosis |
url |
http://link.springer.com/article/10.1186/s12885-019-5944-2 |
work_keys_str_mv |
AT hairuyu setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT jiayisun setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT congxuanzhao setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT haotianwang setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT yeqiuliu setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT jiajiaxiong setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT jingchang setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT mixuewang setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT wenhuiwang setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT dongmanye setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT hongyanzhou setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients AT taoyu setdomaincontainingprotein5setd5enhancestumorcellinvasionandisassociatedwithapoorprognosisinnonsmallcelllungcancerpatients |
_version_ |
1724750230261334016 |